The National Standard for pharmaceuticals manufacture and quality control, RF GOST R 52249-2004 (being an authentic translation of EU Pharmaceuticals Good Manufacturing Practices regulations), came into effect on January 1st, 2005. One of the purposes of the pharmaceutical industry switching to international standards is providing the country populace with modern highly effective medications of a quality adequate to that of foreign analogs but at lower retail prices.
Pharmsynthez is an active participant of a nation-wide pharmaceutical business transition to international regulations. In particular, Quality Policy and Objectives for the years 2006-2007 make provisions for preparation to ISO certification and getting enterprise quality management system ISO-certified and attested for conformity with EU GMP. When achieved, these steps will enable the Company to manufacture pharmaceuticals of international quality standard locally and establish cooperation with leading domestic and foreign manufacturers on new dosage forms (ampoules, tablets, capsules, etc.) production.